Even before diabetes develops, dysglycaemia may increase AF risk. ⚠️
A meta-analysis including 26.4 million participants showed that prediabetes was associated with ⬆️15% risk of AF, supporting a dose–response relationship across glucose levels.
🔗https://t.co/KhJ8mp845N
🏃♂️ More than 1 in 3 athletes show elevated cardiac troponin levels after exercise. This meta-analysis highlights that elevations are most common after endurance events lasting 3–6 h and with high-sensitivity cTnT assays.🫀
🔗https://t.co/JvL7v7N9gj
#sportscardiology
Great science matters — but so do the people, collaborations, and conversations that make the EAS community special.
Who are you excited to see at #EASCongress2026?
#EAS2026#RoadToEASCongress2026
New in #EJPC: Cuffless Blood Pressure Monitoring Devices: Technical Foundations and Clinical Implications: Scientific Statement of the European Society of Cardiology (ESC) Working Group on e-Cardiology, the ESC Council on Hypertension, and the European Association of Preventive Cardiology of the ESC
https://t.co/9sFxL5OtLg
@EJPCEiC@AboyansV@SilCastelletti@PTBuketAkinci@PeroneFrancesco@SMosteoru@TimKambic
We’re kicking off the #EASCongress2026 Scavenger Hunt with the first hint!
Find a first envelope and win a special experience in Gothenburg, Sweden - the host city of EAS Congress 2027.
🔗 Find out more about the scavenger hunt: https://t.co/LVlm4JewON
#Atherosclerosis
Sunday morning congress prep: download the #EASCongress2026 app before the first sessions start
Your future self, trying to be in three places at once, will thank you :)
🔗https://t.co/lHm05zsvY9
@EASCongress@society_eas#EASSoMe#MyEAS2026
Resistant hypertension remains a high-risk condition but lower BP targets may help.
The STEP trial analysis found intensive BP control (<130 mmHg) was associated with substantially fewer cardiovascular events (64% ⬇️), without added safety concerns.
https://t.co/3DAe7gsFUO
New from the Hordaland Health Study: elevated BP in early midlife was linked to greater arterial stiffness 27 years later in women but not in men. A powerful signal for earlier and sex-specific cardiovascular prevention. 🫀♀️
https://t.co/VSWPerHOOd
We’re ready to announce another Rare Lipid Disorder Course! This time, Argentina 🇦🇷 invites all LatAm members to Buenos Aires to learn from leading experts in the field. Check out the fantastic programme and speaker line-up. After that, register to secure your spot: https://t.co/UfkDmqke5Y @lschreier1@drpablocorral
New issue of #EJPC released for “World Hypertension Day” is focused on HT care from precision BP phenotyping and vascular ageing to cuffless monitoring, digital health, renal denervation, and sex-specific prevention strategies.
🔗https://t.co/noGBKcJShV